XML 60 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Component of Consolidated Income (Loss) Before Provision for Income Taxes

Consolidated income (loss) before provision for income taxes consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

U.S.

 

$

(95,898

)

 

$

(114,484

)

 

$

(107,450

)

Non U.S.

 

 

744

 

 

 

2,040

 

 

 

656

 

Total

 

$

(95,154

)

 

$

(112,444

)

 

$

(106,794

)

 

Difference Between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate

No income tax expense was recorded for the years ended December 31, 2017, 2016 and 2015 due to net operating loss carryforwards to offset the net income at Dynavax GmbH and a valuation allowance which offsets the deferred tax assets. The difference between the consolidated income tax benefit and the amount computed by applying the federal statutory income tax rate to the consolidated loss before income taxes was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Income tax benefit at federal statutory rate

 

$

(32,352

)

 

$

(38,183

)

 

$

(36,301

)

State tax

 

 

(4,482

)

 

 

(334

)

 

 

(394

)

Business credits

 

 

(1,960

)

 

 

(1,950

)

 

 

(2,622

)

Deferred compensation charges

 

 

3,823

 

 

 

3,016

 

 

 

1,481

 

Change in valuation allowance

 

 

(109,165

)

 

 

36,751

 

 

 

36,766

 

Rate change

 

 

86,943

 

 

 

-

 

 

 

-

 

Net operating loss and tax credit limitation

 

 

56,962

 

 

 

-

 

 

 

-

 

Other

 

 

231

 

 

 

700

 

 

 

1,070

 

Total income tax expense

 

$

-

 

 

$

-

 

 

$

-

 

 

Component of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities consisted of the following (in thousands): 

 

 

 

December 31,

 

 

 

2017

 

 

2016

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss carry forwards

 

$

146,300

 

 

$

249,510

 

Research tax credit carry forwards

 

 

29,658

 

 

 

29,463

 

Accruals and reserves

 

 

6,551

 

 

 

8,684

 

Capitalized research costs

 

 

1,422

 

 

 

4,457

 

Other

 

 

731

 

 

 

1,303

 

Total deferred tax assets

 

 

184,662

 

 

 

293,417

 

Less valuation allowance

 

 

(184,388

)

 

 

(293,145

)

Net deferred tax assets

 

 

274

 

 

 

272

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Fixed assets

 

 

(274

)

 

 

(272

)

Total deferred tax liabilities

 

 

(274

)

 

 

(272

)

Net deferred tax assets

 

$

-

 

 

$

-

 

 

Schedule of Unrecognized Tax Benefits

The following table summarizes the activity related to the Company’s unrecognized tax benefits:

 

Balance at December 31, 2016

 

$

(2,426

)

Tax positions related to the current year

 

 

 

 

  Additions

 

 

-

 

  Reductions

 

 

-

 

Tax positions related to the prior year

 

 

 

 

  Additions

 

 

-

 

  Reductions

 

 

1,197

 

Balance at December 31, 2017

 

$

(1,229

)